Takeda Pharmaceutical Co Ltd (TAK)

Data as of 2026-09-03.

Key facts

Price
18.28 JPY
Market capitalisation
$58.1B
Dividend yield
6.78%
52-week range
4102.00 - 6033.00
Beta
0.21
Sector
Health Care
Industry
Pharmaceuticals
Country
JP
Exchange
TOKYO STOCK EXCHANGE-TOKYO PRO MARKET
Employees
47 455
IPO date
1949-05-16
Analyst price target
20.52 JPY
Analyst consensus
14 buy / 7 hold / 0 sell
Stoxly score
48.1 / 100
Universe percentile
better than 64% of the analysed universe

About Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.

Website

Similar companies

Full Quality Check for Takeda Pharmaceutical Co Ltd

Stoxly scores rate the quality of the published fundamentals, not the upside of the share price. Nothing on this page is investment advice.